Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
JACC. Advances|August 19, 2025
Clinical Outcomes of Ezetimibe Plus Statins in Patients With Lower Extremity Artery DiseaseYoshihiro Iwasaki, Takenobu Shimada, Takefumi Kishimori, et al.
Journal of Bioscience and Bioengineering|December 19, 2007
Production of single-chain variable fragment antibody (scFv) in fed-batch and continuous culture of Pichia pastoris by two different methanol feeding methodsShinya Yamawaki, Takehiro Matsumoto, Yuka Ohnishi, et al.
Clinical Science (London, England : 1979)|August 24, 2002
Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failureMasato Ohnishi, Atsuyuki Wada, Takayoshi Tsutamoto, et al.
Biological & Pharmaceutical Bulletin|December 8, 2022
Utility of Blood Culture in Patients with Community-Acquired Pneumonia: A Propensity Score-Matched Analysis Based on a Japanese National Health Insurance DatabaseTakahiro Muro, Fumihiko Ando, Marie Suehiro, et al.
Clinical Science (London, England : 1979)|August 24, 2002
Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failureTakashi Yamamoto, Atsuyuki Wada, Masato Ohnishi, et al.
Journal of the American Heart Association|February 8, 2025
Comparative Outcomes of Glucagon-Like Peptide-1 Receptor Agonists to Dipeptidyl Peptidase 4 Inhibitors in Patients With Heart Failure and Type 2 DiabetesTakefumi Kishimori, Takao Kato, Atsuyuki Wada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 24, 2006
Increasing hepatitis C virus-associated hepatocellular carcinoma mortality and aging: Long term trends in JapanNaota Taura, Hiroshi Yatsuhashi, Keisuke Hamasaki, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|July 17, 2025
Cardiovascular Outcomes and Safety of Semaglutide in Non-Overweight Populations with Type 2 Diabetes: A Comparison with Dipeptidyl Peptidase 4 InhibitorsTakefumi Kishimori, Takao Kato, Atsuyuki Wada, et al.
Open Heart|July 8, 2025
Effectiveness of semaglutide on survival outcomes in patients with type 2 diabetes and chronic kidney diseaseTakefumi Kishimori, Takao Kato, Atsuyuki Wada, et al.
Scientific Reports|July 2, 2025
Comparative cardiovascular outcomes of semaglutide to dulaglutide in patients with type 2 diabetesTakefumi Kishimori, Takao Kato, Atsuyuki Wada, et al.
Pageof 5